Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature ...

Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

or about 14% of Medicare Part D’s prescription drug costs, according to CMS. The negotiated prices for the drugs will take effect in 2027. The second round of negotiations builds on the success ...

The Trump administration signaled Medicare drug price negotiations under the Inflation ... not total [Medicare parts B and D] spending,” Holz-Eakin told Health Care News. Under the IRA, CMS has the ...

Dr. Mehmet Oz, the former surgeon and television host, was nominated to head the Centers for Medicare and Medicaid Services.

Dr. Mehmet Oz's confirmation hearing for CMS administrator largely revolved around changes to the Medicaid program, which ...

Under the law, the Centers for Medicare & Medicaid Services (CMS) can negotiate prices for high-expenditure drugs. Manufacturers who disagree with the program’s terms or the proposed pricing are ...

Former heart surgeon and television host Dr. Mehmet Oz testified Friday before the Senate Finance Committee over his nomination to head the Centers for Medicare and Medicaid Services under ...

March 14 (Reuters) - All drug manufacturers, including Novo Nordisk (NOVOb.CO), opens new tab and Teva Pharmaceuticals (TEVA.TA), opens new tab, whose medicines are part of the second round of ...